These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11721155)

  • 1. Relationship between mast cells in the tubulointerstitium and prognosis of patients with IgA nephropathy.
    Kurusu A; Suzuki Y; Horikoshi S; Shirato I; Tomino Y
    Nephron; 2001 Dec; 89(4):391-7. PubMed ID: 11721155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubulointerstitial mast cell infiltration in glomerulonephritis.
    Hiromura K; Kurosawa M; Yano S; Naruse T
    Am J Kidney Dis; 1998 Oct; 32(4):593-9. PubMed ID: 9774120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of mast cells in renal fibrosis in patients with IgA nephropathy.
    Sakamoto-Ihara T; Suzuki Y; Kurusu A; Yamashita M; Horikoshi S; Tomino Y
    Inflamm Res; 2007 Oct; 56(10):421-7. PubMed ID: 18026699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mast cells, stem cell factor and protease-activated receptor-2 in tubulointerstitial lesions in IgA nephropathy.
    Liu H; Liu F; Peng Y; Liu Y; Li L; Tu X; Cheng M; Xu X; Chen X; Ling G; Sun L
    Inflamm Res; 2010 Jul; 59(7):551-9. PubMed ID: 20131076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis.
    Ehara T; Shigematsu H
    Kidney Int; 1998 Nov; 54(5):1675-83. PubMed ID: 9844144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of the proliferation marker Ki-67 in renal biopsies: correlation to clinical findings.
    Nabokov A; Waldherr R; Ritz E
    Am J Kidney Dis; 1997 Jul; 30(1):87-97. PubMed ID: 9214406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the tubulointerstitial changes in the prognosis of IgA glomerulonephritis.
    Nagy J; Trinn C; Deák G; Schmelzer M; Burger T
    Klin Wochenschr; 1984 Nov; 62(22):1094-6. PubMed ID: 6513436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of the interstitial mast cells in idiopathic mesangiocapillary glomerulonephritis type I.
    Danilewicz M; Wagrowska-Danilewicz M
    Nefrologia; 2001; 21(3):253-9. PubMed ID: 11471306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cells: the forgotten cells of renal fibrosis.
    Roberts IS; Brenchley PE
    J Clin Pathol; 2000 Nov; 53(11):858-62. PubMed ID: 11127270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nestin is a novel marker for renal tubulointerstitial injury in immunoglobulin A nephropathy.
    Tomioka M; Hiromura K; Sakairi T; Takeuchi S; Maeshima A; Kaneko Y; Kuroiwa T; Takeuchi T; Nojima Y
    Nephrology (Carlton); 2010 Aug; 15(5):568-74. PubMed ID: 20649878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Renal Mast Cell Density Is Associated with Poor Prognosis in Patients with Immunoglobulin A Nephropathy.
    Wang S; Hu D; Li YQ; Lei Q; Liu L; He X; Han M; Pei G; Zeng R; Xu G
    Am J Nephrol; 2023; 54(3-4):106-116. PubMed ID: 37245508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic study on prognostic markers in IgA nephropathy.
    Mera J; Uchida S; Nagase M
    Nephron; 2000 Feb; 84(2):148-57. PubMed ID: 10657716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial inflammatory and chronic tubulointerstitial lesions in lupus nephritis: comparison with those in IgA nephropathy.
    Yamamoto T; Nagase M; Hishida A; Honda N
    Lupus; 1993 Aug; 2(4):261-8. PubMed ID: 8268975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis.
    Jinde K; Nikolic-Paterson DJ; Huang XR; Sakai H; Kurokawa K; Atkins RC; Lan HY
    Am J Kidney Dis; 2001 Oct; 38(4):761-9. PubMed ID: 11576879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic correlation in IgA nephropathy.
    Philibert D; Cattran D; Cook T
    Semin Nephrol; 2008 Jan; 28(1):10-7. PubMed ID: 18222342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Biopsy: An Experience from Tertiary Hospital.
    Ghimire M; Pahari B; Paudel N; Das G; Das GC; Sharma SK
    JNMA J Nepal Med Assoc; 2014; 52(193):707-12. PubMed ID: 26905553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for abundant presence of chymase-positive mast cells in the kidneys of patients with immunoglobulin A nephropathy: effect of combination therapy with prednisolone and angiotensin II receptor blocker valsartan.
    Konishi Y; Morikawa T; Okada N; Maeda I; Kitabayashi C; Yoshioka K; Okumura M; Nishiyama A; Ueda M; Takai S; Miyazaki M; Imanishi M
    Hypertens Res; 2008 Aug; 31(8):1517-24. PubMed ID: 18971525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell infiltration associated with tubulointerstitial fibrosis in chronic Aristolochic Acid Nephropathy.
    Wu Y; Liu Z; Hu W; Li L
    Hum Exp Toxicol; 2005 Feb; 24(2):41-7. PubMed ID: 15850277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological significance of intratubular giant macrophages in progressive glomerulonephritis.
    Oda T; Hotta O; Taguma Y; Kitamura H; Sugai H; Onodera S; Horigome I; Suzuki K; Shouji Y; Furuta T; Chiba S; Yoshizawa N; Nagura H
    Kidney Int; 1998 May; 53(5):1190-200. PubMed ID: 9573533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell infiltration is involved in renal interstitial fibrosis in a rat model of protein-overload nephropathy.
    Li Y; Zhou L; Liu F; Peng Y; Li J; Sun L; Duan S; Ling G; Chen X; Jiang W; Xia Y
    Kidney Blood Press Res; 2010; 33(3):240-8. PubMed ID: 20606473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.